Search Results - "Labianca R"

Estimation of ocean-surface directional-frequency spectra.

Authors: Labianca, R. M.

Source: Journal of the Acoustical Society of America; May 1980, Vol. 67, p1567-1577, 11p

Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy.

Authors: Passalacqua R Campione F Caminiti C et al.

Source: Lancet. 4/17/1999, Vol. 353 Issue 9161, p1310-1314. 5p.

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

Authors: Rougier, Philippe Van Cutsem, Eric Bajetta, Emilio et al.

Source: Lancet. 10/31/1998, Vol. 352 Issue 9138, p1407-1412. 6p. 1 Diagram, 5 Charts, 3 Graphs.

Subjects: Camptothecin, Fluorouracil, Colon cancer, Metastasis, Cancer chemotherapy, Drug therapy, Therapeutics

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.

Authors: Rougier P Sahmoud T Nitti D et al.

Source: Lancet. 6/6/1998, Vol. 351 Issue 9117, p1677-1681. 5p.

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial.

Authors: Labianca, R. Sobrero, A. Isa, L. et al.

Source: Annals of Oncology. May2011, Vol. 22 Issue 5, p1236-1242. 7p. 1 Diagram, 4 Charts, 1 Graph.

The role of adjuvant chemotherapy in colon cancer

Authors: Labianca, R. Milesi, L. Mosconi, S. et al.

Source: Surgical Oncology. Dec2007 Supplement, Vol. 16, p93-96. 4p.

Prevention and treatment of pandemic influenza in cancer patients.

Authors: Francisci, D. Labianca, R. Roila, F.

Source: Annals of Oncology. Dec2010, Vol. 21 Issue 12, p2301-2303. 3p.

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Authors: Cascinu, S. Scartozzi, M. Labianca, R. et al.

Source: British Journal of Cancer. 4/19/2004, Vol. 90 Issue 8, p1521-1525. 5p. 1 Diagram, 3 Charts, 1 Graph.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Authors: Petrelli, F. Rulli, E. Labianca, R. et al.

Source: Annals of Oncology. Jan2021, Vol. 32 Issue 1, p66-76. 11p.

DIFFERENTIAL EXPRESSION OF HEMOSTATIC BIOMARKERS ACROSS CANCER TYPE AND DISEASE STAGE: A PROSPECTIVE ANALYSIS OF 4,292 PATIENTS FROM THE HYPERCAN STUDY.

Authors: Gómez-Rosas, P. Romeo, D. Bolognini, S. et al.

Source: Bleeding, Thrombosis & Vascular Biology. 2026 Supplement, Vol. 5, p220-220. 1p.

PREDICTORS OF ONE-YEAR MORTALITY IN NEWLY DIAGNOSED METASTATIC BREAST CANCER: THE PROGNOSTIC ROLE OF HEMOSTATIC BIOMARKERS AND EARLY THROMBOEMBOLISM.

Authors: Marchetti, M. Gomez-Rosas, P. Bolognini, S. et al.

Source: Bleeding, Thrombosis & Vascular Biology. 2026 Supplement, Vol. 5, p222-222. 1p.

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors: Argilés, G. Tabernero, J. Labianca, R. et al.

Source: Annals of Oncology. Oct2020, Vol. 31 Issue 10, p1291-1305. 15p.

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

Authors: Bastiaenen, V. P. Hovdenak Jakobsen, I. Labianca, R. et al.

Source: Colorectal Disease. Apr2019, Vol. 21 Issue 4, p392-416. 25p.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Authors: Labianca, R. Nordlinger, B. Beretta, G. D. et al.

Source: Annals of Oncology. Oct2013, Vol. 24 Issue suppl_6, pvi64-vi72. 1p.

Treatment of advanced pancreatic cancer.

Authors: Labianca, R. Merelli, B. Mosconi, S.

Source: Annals of Oncology. Sep2012 Supplement 10, Vol. 23 Issue suppl_10, px139-x140. 1p.

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up.

Authors: Labianca, R. Nordlinger, B. Beretta, G. D. et al.

Source: Annals of Oncology. May2010, Vol. 21 Issue suppl_5, pv70-v77. 1p. 1 Chart.

Perioperative or postoperative therapy for resectable gastric cancer?

Authors: Labianca, R. Sburlati, P. Quadri, A. et al.

Source: Annals of Oncology. Jun2008 Supplement 5, Vol. 19, pv99-v102. 1p.

Episodic (Breakthrough) Pain Prevalence in a Population of Cancer Pain Patients. Comparison of Clinical Diagnoses With the QUDEI-Italian Questionnaire for Intense Episodic Pain.

Authors: Caraceni A Bertetto O Labianca R et al.

Source: Journal of Pain & Symptom Management. May2012, Vol. 43 Issue 5, p833-841. 9p.

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.

Authors: Celio, L. Sternberg, C. N. Labianca, R. et al.

Source: Annals of Oncology. Jun2009, Vol. 20 Issue 6, p1062-1067. 6p. 4 Charts.

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.

Authors: Cascinu S Berardi R Labianca R et al.

Source: Lancet Oncology. Jan2008, Vol. 9 Issue 1, p39-44. 6p.